ASTRAZENECA PHARMA
Long

Long

81
Overall Recommendation: Buy/Hold

- AstraZeneca Pharma India shows strong fundamentals, innovation-led growth, and leadership in key therapeutic areas. For long-term investors, especially those focused on growth and sustainability, it is a good **buy**. Investors already holding the stock may consider adding more shares based on their risk appetite and portfolio strategy. However, it’s important to monitor the stock for any regulatory changes or shifts in the competitive landscape.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.